lacosamide
lacosamide is listed in the FDA National Drug Code directory with 42 NDC codes, marketed under brand names including Vimpat, Lacosamide, lacosamide. Available dosage forms: tablet, film coated, powder, injection, capsule, extended release, injection, solution.
Drug Details
- Generic Name
- lacosamide
- Brand Names
- Vimpat, Lacosamide, lacosamide, MOTPOLY XR
- Application Number
- NDA022253
- Sponsor
- UCB, Inc.
- NDC Codes
- 42
- Dosage Forms
- TABLET, FILM COATED, POWDER, INJECTION, CAPSULE, EXTENDED RELEASE, INJECTION, SOLUTION, SOLUTION
- Routes
- ORAL, INTRAVENOUS
- Active Ingredients
- LACOSAMIDE
Indications and Usage
1 INDICATIONS AND USAGE Lacosamide tablets are indicated for: • Treatment of partial-onset seizures in patients 1 month of age and older ( 1.1 ) • Adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older ( 1.2 ) 1.1 Partial-Onset Seizures Lacosamide tablets are indicated for the treatment of partial-onset seizures in patients 1 month of age and older. 1.2 Primary Generalized Tonic-Clonic Seizures Lacosamide tablets are indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in patients 4 years of age and older.